Skip to search formSkip to main contentSkip to account menu

Tromexan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
The influence on the one-stage prothrombin time (Quick index), prothrombin + proconvertin activity, platelet count and fibrinogen… 
1955
1955
Current concepts of deficiency of serum prothrombin conversion accelerator (SPCA) metabolism are all related to prothrombin and… 
1954
1954
(P.I.D.) was an anticoagulant whicheffectively altered theone-stage prothrombin timeithasbeenusedextensively in thetreatment… 
1952
1952
between income and haemoglobin level, but this might be explained by the higher-paid workers being older and leading a more… 
1952
1952
one hand, James et al. (1949) stated that water-soluble preparations (menadione (menaphthone B.P.) and " synkavit "), in large… 
1951
1951
TROMEXAN, a new anticoagulant, has recently been accepted for general use. Chemically, it is described as ethyl biscoumacetate (3… 
1951
1951
Conclusions (1) Tromexan in amounts of .005 to .2 mg partitions from 1 ml of acidified plasma into 5 ml of 2,2,4-trimethylpentane… 
1951
1951
The common use of dicumarinyl derivatives for the treatment of thromboembolic diseases justifies further clinical evaluation of… 
1951
1951
There -is now wide acceptance of the value of anticoagulant therapy. The necessity for prolonged courses of heparin was obviated…